Powder Systems Limited's Laboratory Filter–Dryer Enables Scalability - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Powder Systems Limited's Laboratory Filter–Dryer Enables Scalability


The GFD laboratory nutsche filter–dryer from Powder Systems Limited (PSL), originally in glass, is now available in metal to allow higher pressures. The laboratory-scale unit can be used for feasibility studies and trials before scaling up to a commercial-scale agitated nutsche filter dryer (ANFD). The stainless-steel or alloy 22 versions allow better replication of the pressures in commercial ANFD.  

The smallest "Mini Lab GFD" laboratory unit has a total volume of 0.3 L that can filter a cake volume up to 0.1 L and is suitable for laboratory-scale trials. The "Lab GFD" size includes a removable filtration basket of 0.01-m² for a cake volume of 0.5 L for small-scale synthesis, and the "Maxi Lab GFD" filters a cake volume of 5 L with 0.05-m² filtration area.
 

Source: Powder Systems Limited

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here